• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vectura Group PLC

+ Add to Watchlist

VEGPF:US

2.1500 USD 0.00000.00%

As of 20:10:01 ET on 11/24/2014.

Snapshot for Vectura Group PLC (VEGPF)

Open: - Day's Range: - Volume: 500
Previous Close: 2.1500 52wk Range: 1.9700 - 2.9922 1-Yr Rtn: -

Stock Chart for VEGPF

No chart data available.
  • VEGPF:US 2.1500
  • 1D
  • 1M
  • 1Y
2.1500
Interactive VEGPF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VEGPF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 273.6936
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.0050
Est. PEG Ratio -
Market Cap (M USD) 865.30
Shares Outstanding (M) 402.46
30 Day Average Volume 33
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VEGPF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for VEGPF

Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.

Christopher Paul Blackwell "Chris"CEO/Executive DirectorPaul OliverCFO/Exec Dir/Secretary
Gerhard ScheuchChief Scientific OfficerKarl D KeeganChief Corporate Dev Officer
More Company Profile & Key Executives for VEGPF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil